In some malignant cancers, such as breast, prostate, and parathyroid cancers, abnormal expression of CaSR is associated with highly aggressive and metastatic tumor cells (Chakravarti et al., 2009; Ying et al., 2023). Here, CASR is linked to metastatic neoplasm.